Hematologic Oncology Update
By Dr. Neil Love
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Dr. Neil Love
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 43
Reviews: 0
Episodes: 138
Description
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
| Episode | Date |
|---|---|
|
Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances
|
Apr 20, 2026 |
|
CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson
|
Apr 10, 2026 |
|
Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review
|
Apr 01, 2026 |
|
CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson
|
Mar 23, 2026 |
|
Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review
|
Mar 21, 2026 |
|
CD19 x CD3 BiTEs for Acute Lymphoblastic Leukemia — An Interview with Dr Bijal Shah
|
Mar 13, 2026 |
|
Chronic Lymphocytic Leukemia — An Interview with Prof Constantine Tam on Key Presentations from the 2025 ASH Annual Meeting
|
Mar 11, 2026 |
|
Immune Thrombocytopenia — Microlearning Activity 2 with Dr Hanny Al-Samkari: ASH 2025 Review
|
Mar 09, 2026 |
|
Immune Thrombocytopenia — Microlearning Activity 1 with Dr Hanny Al-Samkari: ASH 2025 Review
|
Mar 04, 2026 |
|
Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators
|
Feb 18, 2026 |
|
Relapsed/Refractory Multiple Myeloma — Microlearning Activity 2 with Dr Sagar Lonial: ASH 2025 Review
|
Feb 13, 2026 |
|
Immune Thrombocytopenia — ASH 2025 Review
|
Feb 06, 2026 |
|
Relapsed/Refractory Multiple Myeloma — Microlearning Activity 1 with Dr Sagar Lonial: ASH 2025 Review
|
Feb 03, 2026 |
|
Bispecific Antibodies in the Management of Lymphoma — ASH 2025 Review
|
Jan 21, 2026 |
|
Relapsed/Refractory Multiple Myeloma — ASH 2025 Review
|
Jan 16, 2026 |
|
Follicular Lymphoma and Diffuse Large B-Cell Lymphoma — Proceedings from a Symposium Series Preceding the 67th ASH Annual Meeting and Exposition
|
Jan 13, 2026 |
|
Myelofibrosis and Systemic Mastocytosis — Proceedings from a Symposium Series Preceding the 67th ASH Annual Meeting and Exposition
|
Jan 09, 2026 |
|
Chronic Lymphocytic Leukemia — Proceedings from a Symposium Series Preceding the 67th ASH Annual Meeting and Exposition
|
Jan 07, 2026 |
|
Acute Myeloid Leukemia — Proceedings from a Symposium Series Preceding the 67th ASH Annual Meeting and Exposition
|
Jan 03, 2026 |
|
Chronic Lymphocytic Leukemia — Proceedings from a Symposium Held in Partnership with the American Oncology Network
|
Dec 12, 2025 |
|
CAR T-Cell Therapy for Non-Hodgkin Lymphoma | Cancer Q&A — Discussing Common Questions Posed by Patients
|
Dec 11, 2025 |
|
Toxicities Associated with CAR T-Cell Therapy — An Interview with Dr Matthew Lunning
|
Dec 04, 2025 |
|
Patient Education Resource: Non-Hodgkin Lymphoma — Clinical Experts Address Common Questions Posed by Patients About CAR T-Cell Therapy
|
Nov 15, 2025 |
|
Diffuse Large B-Cell Lymphoma and Follicular Lymphoma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
|
Nov 13, 2025 |
|
Acute Myeloid Leukemia — An Interview with Dr Eunice S Wang to Review Key Presentations from ASCO and EHA
|
Oct 23, 2025 |
|
Non-Hodgkin Lymphoma — The Implications of Recent Datasets for Current and Future Disease Management
|
Oct 18, 2025 |
|
Follicular Lymphoma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual Meeting
|
Oct 10, 2025 |
|
Acute Myeloid Leukemia — An Interview with Dr Ghayas Issa on the Role of Menin Inhibitors
|
Oct 09, 2025 |
|
Relapsed/Refractory Multiple Myeloma — Proceedings from a Session Held During the Society of Hematologic Oncology 2025 Annual Meeting
|
Oct 03, 2025 |
|
Oncology Nursing Update: Multiple Myeloma — An Interview with Dr Beth Faiman on CAR T-Cell Therapy
|
Sep 19, 2025 |
|
Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies: Part 2 — An Interview with Dr Neel Pasricha on Adverse Event Management
|
Sep 16, 2025 |
|
Ocular Toxicities Associated with Antibody-Drug Conjugates and Other Cancer Therapies: Part 1 — Inside the Issue of Adverse Event Management
|
Sep 15, 2025 |
|
Oncology Nursing Update: Newly Diagnosed Multiple Myeloma — An Interview with Ms Charise Gleason
|
Sep 06, 2025 |
|
Oncology Nursing Update: Newly Diagnosed Multiple Myeloma — An Interview with Prof Xavier Leleu
|
Sep 05, 2025 |
|
Relapsed/Refractory Multiple Myeloma — Oncology Q&A: Discussing Common Questions Posed by Patients
|
Aug 29, 2025 |
|
Multiple Myeloma | Oncology Q&A — Patient Education Resource: Clinical Experts Address Common Questions Posed by Patients with Relapsed/Refractory Multiple Myeloma
|
Aug 15, 2025 |
|
Acute Myeloid Leukemia — An Interview with Dr Jorge Cortes on Optimal Management of FLT3 and IDH1/2 Mutations
|
Aug 12, 2025 |
|
Multiple Myeloma — Optimizing the Selection of First-Line Therapy
|
Aug 07, 2025 |
|
Chronic Lymphocytic Leukemia — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
|
Jul 22, 2025 |
|
Multiple Myeloma — Proceedings from a Webinar Held in Conjunction with the 2025 ASCO Annual Meeting
|
Jul 18, 2025 |
|
For Oncology Nurses: Chronic Lymphocytic Leukemia — Proceedings from the 2025 Annual ONS Congress
|
Jul 14, 2025 |
|
Non-Hodgkin Lymphoma — Proceedings from a Session Held During the 2025 ASCO Annual Meeting
|
Jul 10, 2025 |
|
For Oncology Nurses: Non-Hodgkin Lymphoma — Proceedings from the 2025 Annual ONS Congress
|
Jul 05, 2025 |
|
For Oncology Nurses: Chronic Myeloid Leukemia — Proceedings from the 2025 Annual ONS Congress
|
Jun 28, 2025 |
|
IDH-Mutant Low-Grade Glioma — An Interview with Dr Patrick Y Wen on Current and Future Management Strategies
|
Jun 24, 2025 |
|
Multiple Myeloma — Year in Review Series on Relevant New Datasets and Advances
|
Jun 18, 2025 |
|
Myelofibrosis — Year in Review Series on Relevant New Datasets and Advances
|
Jun 11, 2025 |
|
Non-Hodgkin Lymphoma — Year in Review Series on Relevant New Datasets and Advances
|
Jun 05, 2025 |
|
Systemic Mastocytosis and Myelofibrosis — Fourth Annual National General Medical Oncology Summit
|
Jun 02, 2025 |
|
Multiple Myeloma — Fourth Annual National General Medical Oncology Summit
|
May 31, 2025 |
|
Multiple Myeloma — An Interview with Dr Rafael Fonseca on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
|
May 29, 2025 |
|
Chronic Lymphocytic Leukemia — An Interview with Dr Lindsey Roeker on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
|
May 25, 2025 |
|
Relapsed/Refractory Follicular Lymphoma Part 3 — A Roundtable Discussion on the Selection and Sequencing of Other Novel Therapies
|
May 23, 2025 |
|
Non-Hodgkin Lymphoma — An Interview with Dr Jennifer Crombie on the Use of Bispecific Antibodies
|
May 20, 2025 |
|
Relapsed/Refractory Follicular Lymphoma Part 2 — A Roundtable Discussion on the Selection and Sequencing of CAR T-Cell Therapy
|
May 16, 2025 |
|
Non-Hodgkin Lymphoma — Fourth Annual National General Medical Oncology Summit
|
May 12, 2025 |
|
Non-Hodgkin Lymphoma — An Interview with Dr John P Leonard on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
|
May 10, 2025 |
|
Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances
|
May 03, 2025 |
|
Immune Thrombocytopenia — A Roundtable Discussion on Current and Future Management Strategies
|
Apr 28, 2025 |
|
Relapsed/Refractory Follicular Lymphoma Part 1 — A Roundtable Discussion on the Selection and Sequencing of Bispecific Antibodies
|
Apr 22, 2025 |
|
Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 2
|
Apr 18, 2025 |
|
Myelofibrosis — An Interview with Dr Raajit K Rampal on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
|
Apr 15, 2025 |
|
Chronic Lymphocytic Leukemia — Fourth Annual National General Medical Oncology Summit
|
Apr 12, 2025 |
|
Chronic Lymphocytic Leukemia — An Interview with Dr Catherine C Coombs on Real-World Cases and Current Questions and Controversies Presented at Recent Conferences
|
Apr 04, 2025 |
|
For Oncology Nurses: Bispecific Antibodies in Multiple Myeloma — An Interview with Dr Tiffany A Richards
|
Mar 24, 2025 |
|
Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 1
|
Mar 18, 2025 |
|
Relapsed/Refractory Diffuse Large B-Cell Lymphoma — A Roundtable Discussion on Current and Future Management Strategies
|
Feb 25, 2025 |
|
Multiple Myeloma — An Interview with Dr Surbhi Sidana on Optimizing the Role of CAR T-Cell Therapy
|
Feb 19, 2025 |
|
Multiple Myeloma — Optimizing the Selection of First-Line Therapy with Dr Saad Zafar Usmani
|
Feb 11, 2025 |
|
Chronic Lymphocytic Leukemia with Dr Jennifer Woyach: Part 3 of a 3-Part Meet The Professor Series
|
Jan 30, 2025 |
|
Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
|
Jan 23, 2025 |
|
CAR T-Cell and Bispecific Therapy for Lymphoma — Part 3 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
|
Jan 16, 2025 |
|
Myelofibrosis — Part 4 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
|
Jan 14, 2025 |
|
Chronic Myeloid Leukemia — Part 1 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
|
Jan 09, 2025 |
|
Acute Myeloid Leukemia — Part 5 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
|
Jan 07, 2025 |
|
Multiple Myeloma — Part 6 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
|
Dec 20, 2024 |
|
Chronic Lymphocytic Leukemia — Part 2 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
|
Dec 19, 2024 |
|
Cases from the Community: Integrating New Research Findings into Current Practice — Myelofibrosis
|
Dec 17, 2024 |
|
Cases from the Community: Integrating New Research Findings into Current Practice — Leukemia and Myelodysplastic Syndromes
|
Dec 13, 2024 |
|
Practical Perspectives: Investigators Discuss the Current Management of Paroxysmal Nocturnal Hemoglobinuria
|
Dec 04, 2024 |
|
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Multiple Myeloma
|
Nov 26, 2024 |
|
Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 2 of a 3-Part Series
|
Nov 22, 2024 |
|
Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current Oncology Care — Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
|
Nov 20, 2024 |
|
What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma
|
Nov 08, 2024 |
|
Practical Perspectives: Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell Lymphoma
|
Oct 30, 2024 |
|
Practical Perspectives: Current Management of Chronic Myeloid Leukemia
|
Oct 24, 2024 |
|
Oncology Today with Dr Neil Love: Peripheral T-Cell Lymphoma
|
Oct 17, 2024 |
|
Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 1 of a 3-Part Series
|
Oct 10, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
|
Aug 12, 2024 |
|
RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma
|
Jul 12, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis
|
Jul 02, 2024 |
|
Oncology Today with Dr Neil Love: Key Presentations on Lymphoma from Recent Major Conferences
|
May 29, 2024 |
|
Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
|
May 28, 2024 |
|
Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma
|
May 24, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia
|
May 14, 2024 |
|
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series
|
May 02, 2024 |
|
Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria
|
Apr 26, 2024 |
|
Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences
|
Apr 24, 2024 |
|
Oncology Today with Dr Neil Love: Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences
|
Apr 12, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma
|
Mar 27, 2024 |
|
Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series
|
Mar 08, 2024 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia
|
Feb 27, 2024 |
|
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series
|
Jan 17, 2024 |
|
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 2 of a 3-Part Series
|
Nov 10, 2023 |
|
Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of a 3-Part Series
|
Oct 20, 2023 |
|
What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma
|
Oct 19, 2023 |
|
Oncology Today with Dr Neil Love: Key Presentations on Multiple Myeloma from Recent Major Oncology/Hematology Conferences
|
Oct 18, 2023 |
|
Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar
|
Oct 12, 2023 |
|
What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma
|
Oct 09, 2023 |
|
Oncology Today with Dr Neil Love: Blastic Plasmacytoid Dendritic Cell Neoplasm
|
Oct 05, 2023 |
|
Oncology Today with Dr Neil Love: Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma
|
Sep 28, 2023 |
|
What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors
|
Sep 22, 2023 |
|
Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
|
Sep 14, 2023 |
|
Oncology Today with Dr Neil Love: Role of BTK Inhibitors in Patients with Mantle Cell Lymphoma
|
Aug 31, 2023 |
|
Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 2 of a 2-Part Series
|
Aug 30, 2023 |
|
Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Chronic Lymphocytic Leukemia and Lymphoma from Recent Major Oncology/Hematology Conferences
|
Aug 29, 2023 |
|
Inside the Issue: Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management
|
Aug 23, 2023 |
|
Oncology Today with Dr Neil Love: Special Edition — What I Tell My Patients About New Treatments and Clinical Trials in Chronic Lymphocytic Leukemia
|
Aug 18, 2023 |
|
Inside the Issue: Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes
|
Aug 02, 2023 |
|
Oncology Today with Dr Neil Love: Immune Thrombocytopenia Edition
|
Jul 31, 2023 |
|
Oncology Today with Dr Neil Love: Management of Paroxysmal Nocturnal Hemoglobinuria
|
Jul 26, 2023 |
|
Meet The Professor: The Current and Future Management of Non-Hodgkin Lymphoma
|
Jul 10, 2023 |
|
Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 1 of a 2-Part Series
|
Jun 16, 2023 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia and Myelodysplastic Syndromes
|
Apr 21, 2023 |
|
Oncology Today with Dr Neil Love: Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Multiple Myeloma Edition
|
Apr 19, 2023 |
|
Oncology Today with Dr Neil Love — Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting: Chronic Lymphocytic Leukemia Edition
|
Apr 12, 2023 |
|
Recent Advances and Future Directions in Chronic Lymphocytic Leukemia and Lymphomas — With Dr Danielle Brander and Craig Moskowitz (Proceedings from a Symposium in Partnership with NCOA and SCOS)
|
Mar 17, 2023 |
|
Oncology Today with Dr Neil Love: Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting
|
Mar 02, 2023 |
|
Inside the Issue — Optimizing the Management of Adverse Events Associated with BTK Inhibitors
|
Feb 23, 2023 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hodgkin and Non-Hodgkin Lymphomas
|
Feb 17, 2023 |
|
Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 4 of a 4-Part Series
|
Feb 14, 2023 |
|
Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting
|
Feb 09, 2023 |
|
Oncology Today with Dr Neil Love: Advances in Diffuse Large B-Cell Lymphoma
|
Feb 06, 2023 |
|
Oncology Today with Dr Neil Love: Key Presentations in Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2022 ASH Annual Meeting
|
Feb 02, 2023 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
|
Feb 01, 2023 |
|
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia
|
Jan 20, 2023 |
|
Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 3 of a 4-Part Series
|
Jan 19, 2023 |
|
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Acute Myeloid Leukemia
|
Jan 13, 2023 |